What is the NOAEL for Cinnamon oil?
Cinnamon oil has 20 NOAEL studies in the database. The lowest reported value is 8 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
NOAEL Data
Cosmetic Ingredient
Cinnamon oil
Also known as: Oils, cinnamon, Essential oils, cinnamon, Oils, essential, cinnamon, Essential oils, cinnamon leaf, Oils, essential, cinnamon leaf (+15 more)
CAS 8015-91-6
Cinnamon oil (CAS 8015-91-6) is a chemical substance. Key regulatory status: 9 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS.
SOURCE
noael studies public
NOAEL studies
20
SOURCE
chemical inventory jurisdictions
Regulatory lists
9
SOURCE
eu clp annex vi
GHS signal
Not classified
Chemical Identity
CAS, identifiers, formula, and alternate names for the matched substance record.
SOURCE
DSSTox identifiers
23 fields
Name
Cinnamon oil
CAS Number
8015-91-6
DTXSID
DTXSID20894625
Synonyms
Oils, cinnamonEssential oils, cinnamonOils, essential, cinnamonEssential oils, cinnamon leafOils, essential, cinnamon leafArtificial cinnamon oilCeylon cinnamon bark oilCeylon cinnamon leaf oilCinnamomum leaf oilCinnamomum oilCinnamomum oilsCinnamomum zeylanicum bark oil
Functional Uses
Industrial and product-use categories associated with this substance.
SOURCE
EPA CPDat
60 records
FragranceFlavouring and nutrient
Regulatory Lists
Inventory, screening, and regulatory list matches from public chemical databases.
SOURCE
EPA CPDat
9 records
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| IFRA Transparency | IFRA | IFRA |
| IFRA Transparency | IFRA | IFRA |
| Australia; Food and drug - smoking-related products | New Zealand ESR | CPCat |
| IFRA Transparency | IFRA | IFRA |
| consumer_product | P&G | Proctor & Gamble |
| IFRA Transparency | IFRA | IFRA |
| IFRA Transparency | IFRA | IFRA |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
NOAEL Studies
Toxicology endpoints rendered from public NOAEL study rows.
SOURCE
NOAEL studies
Showing 20 of 20 studies
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 10.8 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 8 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| E5GY4I6YCZ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| E5GY4I6YCZ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| E5GY4I6YCZ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| E5GY4I6YCZ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| S92U8SQ71V | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| S92U8SQ71V | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| S92U8SQ71V | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| S92U8SQ71V | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| XE54U569EC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| XE54U569EC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| XE54U569EC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| XE54U569EC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| - | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 3.704 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 5039 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 5669 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 6803 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 3 | unitless | Relative reliability score | Dermal | Human | NTP_ICE_skin_sensitization |
Showing 20 of 20 studies
Australian Status (AICIS)
Australian industrial chemicals inventory status and applicable conditions.
SOURCE
AICIS inventory
1 records
Inventory Status
listed
Cosmetic Safety Profile
Same-CAS cosmetic ingredient record for cross-vertical context.
SOURCE
CosIng / Ingredients DB
EU Status
restricted
Max
Cinnamaldehyde (active component, CAS 104-55-2) requires declaration at >0.001% in leave-on products; subject to Annex III restrictions for sensitizing components
Category
active
Frequently Asked Questions
What regulatory lists include Cinnamon oil?
Cinnamon oil appears on 4 regulatory/inventory lists including IFRA Transparency, Australia; Food and drug - smoking-related products, consumer_product, and 1 more. Source: EPA CPDat.
Is Cinnamon oil used in cosmetics?
Yes, Cinnamon oil is also indexed as a cosmetic ingredient under the name Cinnamaldehyde. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Where does the safety data for Cinnamon oil come from?
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, CosIng / Ingredients DB. All data traces to primary regulatory sources and is updated from official government databases.
Is Cinnamon oil used outside industrial chemicals?
Cinnamon oil also appears in cosmetics databases.